Chapter/Section Purchase

1 Study Coverage
1.1 OTC Anti-Infective Products Product Introduction
1.2 Market by Type
1.2.1 Global OTC Anti-Infective Products Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Antifungal
1.2.3 Antibacterial
1.2.4 Antiviral
1.2.5 Antiseptics
1.2.6 Others
1.3 Market by Sales Channel
1.3.1 Global OTC Anti-Infective Products Market Size Growth Rate by Sales Channel, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global OTC Anti-Infective Products Sales Estimates and Forecasts 2017-2028
2.2 Global OTC Anti-Infective Products Revenue Estimates and Forecasts 2017-2028
2.3 Global OTC Anti-Infective Products Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global OTC Anti-Infective Products Sales by Region
2.4.1 Global OTC Anti-Infective Products Sales by Region (2017-2022)
2.4.2 Global Sales OTC Anti-Infective Products by Region (2023-2028)
2.5 Global OTC Anti-Infective Products Revenue by Region
2.5.1 Global OTC Anti-Infective Products Revenue by Region (2017-2022)
2.5.2 Global OTC Anti-Infective Products Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global OTC Anti-Infective Products Sales by Manufacturers
3.1.1 Global Top OTC Anti-Infective Products Manufacturers by Sales (2017-2022)
3.1.2 Global OTC Anti-Infective Products Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of OTC Anti-Infective Products in 2021
3.2 Global OTC Anti-Infective Products Revenue by Manufacturers
3.2.1 Global OTC Anti-Infective Products Revenue by Manufacturers (2017-2022)
3.2.2 Global OTC Anti-Infective Products Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by OTC Anti-Infective Products Revenue in 2021
3.3 Global OTC Anti-Infective Products Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global OTC Anti-Infective Products Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global OTC Anti-Infective Products Sales by Type
4.1.1 Global OTC Anti-Infective Products Historical Sales by Type (2017-2022)
4.1.2 Global OTC Anti-Infective Products Forecasted Sales by Type (2023-2028)
4.1.3 Global OTC Anti-Infective Products Sales Market Share by Type (2017-2028)
4.2 Global OTC Anti-Infective Products Revenue by Type
4.2.1 Global OTC Anti-Infective Products Historical Revenue by Type (2017-2022)
4.2.2 Global OTC Anti-Infective Products Forecasted Revenue by Type (2023-2028)
4.2.3 Global OTC Anti-Infective Products Revenue Market Share by Type (2017-2028)
4.3 Global OTC Anti-Infective Products Price by Type
4.3.1 Global OTC Anti-Infective Products Price by Type (2017-2022)
4.3.2 Global OTC Anti-Infective Products Price Forecast by Type (2023-2028)
5 Market Size by Sales Channel
5.1 Global OTC Anti-Infective Products Sales by Sales Channel
5.1.1 Global OTC Anti-Infective Products Historical Sales by Sales Channel (2017-2022)
5.1.2 Global OTC Anti-Infective Products Forecasted Sales by Sales Channel (2023-2028)
5.1.3 Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2017-2028)
5.2 Global OTC Anti-Infective Products Revenue by Sales Channel
5.2.1 Global OTC Anti-Infective Products Historical Revenue by Sales Channel (2017-2022)
5.2.2 Global OTC Anti-Infective Products Forecasted Revenue by Sales Channel (2023-2028)
5.2.3 Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2017-2028)
5.3 Global OTC Anti-Infective Products Price by Sales Channel
5.3.1 Global OTC Anti-Infective Products Price by Sales Channel (2017-2022)
5.3.2 Global OTC Anti-Infective Products Price Forecast by Sales Channel (2023-2028)
6 North America
6.1 North America OTC Anti-Infective Products Market Size by Type
6.1.1 North America OTC Anti-Infective Products Sales by Type (2017-2028)
6.1.2 North America OTC Anti-Infective Products Revenue by Type (2017-2028)
6.2 North America OTC Anti-Infective Products Market Size by Sales Channel
6.2.1 North America OTC Anti-Infective Products Sales by Sales Channel (2017-2028)
6.2.2 North America OTC Anti-Infective Products Revenue by Sales Channel (2017-2028)
6.3 North America OTC Anti-Infective Products Market Size by Country
6.3.1 North America OTC Anti-Infective Products Sales by Country (2017-2028)
6.3.2 North America OTC Anti-Infective Products Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe OTC Anti-Infective Products Market Size by Type
7.1.1 Europe OTC Anti-Infective Products Sales by Type (2017-2028)
7.1.2 Europe OTC Anti-Infective Products Revenue by Type (2017-2028)
7.2 Europe OTC Anti-Infective Products Market Size by Sales Channel
7.2.1 Europe OTC Anti-Infective Products Sales by Sales Channel (2017-2028)
7.2.2 Europe OTC Anti-Infective Products Revenue by Sales Channel (2017-2028)
7.3 Europe OTC Anti-Infective Products Market Size by Country
7.3.1 Europe OTC Anti-Infective Products Sales by Country (2017-2028)
7.3.2 Europe OTC Anti-Infective Products Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific OTC Anti-Infective Products Market Size by Type
8.1.1 Asia Pacific OTC Anti-Infective Products Sales by Type (2017-2028)
8.1.2 Asia Pacific OTC Anti-Infective Products Revenue by Type (2017-2028)
8.2 Asia Pacific OTC Anti-Infective Products Market Size by Sales Channel
8.2.1 Asia Pacific OTC Anti-Infective Products Sales by Sales Channel (2017-2028)
8.2.2 Asia Pacific OTC Anti-Infective Products Revenue by Sales Channel (2017-2028)
8.3 Asia Pacific OTC Anti-Infective Products Market Size by Region
8.3.1 Asia Pacific OTC Anti-Infective Products Sales by Region (2017-2028)
8.3.2 Asia Pacific OTC Anti-Infective Products Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America OTC Anti-Infective Products Market Size by Type
9.1.1 Latin America OTC Anti-Infective Products Sales by Type (2017-2028)
9.1.2 Latin America OTC Anti-Infective Products Revenue by Type (2017-2028)
9.2 Latin America OTC Anti-Infective Products Market Size by Sales Channel
9.2.1 Latin America OTC Anti-Infective Products Sales by Sales Channel (2017-2028)
9.2.2 Latin America OTC Anti-Infective Products Revenue by Sales Channel (2017-2028)
9.3 Latin America OTC Anti-Infective Products Market Size by Country
9.3.1 Latin America OTC Anti-Infective Products Sales by Country (2017-2028)
9.3.2 Latin America OTC Anti-Infective Products Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa OTC Anti-Infective Products Market Size by Type
10.1.1 Middle East and Africa OTC Anti-Infective Products Sales by Type (2017-2028)
10.1.2 Middle East and Africa OTC Anti-Infective Products Revenue by Type (2017-2028)
10.2 Middle East and Africa OTC Anti-Infective Products Market Size by Sales Channel
10.2.1 Middle East and Africa OTC Anti-Infective Products Sales by Sales Channel (2017-2028)
10.2.2 Middle East and Africa OTC Anti-Infective Products Revenue by Sales Channel (2017-2028)
10.3 Middle East and Africa OTC Anti-Infective Products Market Size by Country
10.3.1 Middle East and Africa OTC Anti-Infective Products Sales by Country (2017-2028)
10.3.2 Middle East and Africa OTC Anti-Infective Products Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Overview
11.1.3 Bayer OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GSK OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Teva
11.3.1 Teva Corporation Information
11.3.2 Teva Overview
11.3.3 Teva OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Teva OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Johnson & Johnson OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Johnson & Johnson Recent Developments
11.5 NOVARTIS
11.5.1 NOVARTIS Corporation Information
11.5.2 NOVARTIS Overview
11.5.3 NOVARTIS OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 NOVARTIS OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 NOVARTIS Recent Developments
11.6 MYLAN
11.6.1 MYLAN Corporation Information
11.6.2 MYLAN Overview
11.6.3 MYLAN OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 MYLAN OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 MYLAN Recent Developments
11.7 Sun Pharma
11.7.1 Sun Pharma Corporation Information
11.7.2 Sun Pharma Overview
11.7.3 Sun Pharma OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sun Pharma OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sun Pharma Recent Developments
11.8 CR SANJIU
11.8.1 CR SANJIU Corporation Information
11.8.2 CR SANJIU Overview
11.8.3 CR SANJIU OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 CR SANJIU OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 CR SANJIU Recent Developments
11.9 Cipla
11.9.1 Cipla Corporation Information
11.9.2 Cipla Overview
11.9.3 Cipla OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Cipla OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Cipla Recent Developments
11.10 Lingrui
11.10.1 Lingrui Corporation Information
11.10.2 Lingrui Overview
11.10.3 Lingrui OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Lingrui OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Lingrui Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 OTC Anti-Infective Products Industry Chain Analysis
12.2 OTC Anti-Infective Products Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 OTC Anti-Infective Products Production Mode & Process
12.4 OTC Anti-Infective Products Sales and Marketing
12.4.1 OTC Anti-Infective Products Sales Channels
12.4.2 OTC Anti-Infective Products Distributors
12.5 OTC Anti-Infective Products Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 OTC Anti-Infective Products Industry Trends
13.2 OTC Anti-Infective Products Market Drivers
13.3 OTC Anti-Infective Products Market Challenges
13.4 OTC Anti-Infective Products Market Restraints
14 Key Findings in The Global OTC Anti-Infective Products Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer